| Product Name |
Subcategory |
Description |
A |
| A2 Cells 3% | Reagent Red Blood Cells | Used to detect ABO blood group antibodies and identifying A1 and A2 subgroups. |
| Abtectcell™ II 0.8% | Reagent Red Blood Cells | Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. |
| Abtectcell™ II 0.8% Pooled | Reagent Red Blood Cells | Used in detecting unexpected alloantibodies. |
| Abtectcell™ II 3% | Reagent Red Blood Cells | Used to detect unexpected alloantibodies using tube technique. |
| Abtectcell™ III 0.8% | Reagent Red Blood Cells | Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. |
| Abtectcell™ III 0.8% RhD Negative Screening Cells | Reagent Red Blood Cells | Used in detecting unexpected alloantibodies other than anti-D. |
| Abtectcell™ III 3% | Reagent Red Blood Cells | Used to detect unexpected alloantibodies using tube technique. |
| ADT Booster® | | For the prevention of diphtheria and tetanus. |
| Advantan | Dermatology | Indicated for the treatment of eczema and psoriasis. |
| AHG Anti-IgG | Anti-Human Globulin Reagent | Used for detection of clinically relevant IgG subtypes. |
| AHG Control Cells 3% | Reagent Red Blood Cells | Used for the confirmation of antiglobulin activity. |
| ALBUMEX® 4 | Critical Care | Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. |
| ALBUMEX® 4 | Critical Care | Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. |
| ALBUMEX® 20 | Critical Care | Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. |
| ALBUMEX® 20 | Critical Care | Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. |
| Angiomax | Cardiovascular | Used to help prevent unwanted blood clotting during an "angioplasty." |
| Anti-A1 | ABO Reagent | Used to detect Group A1 red cells. |
| Anti-Fya | Phenotyping Reagent | Used to detect the presence of the Fya antigen on human red cells. |
| Anti-Fyb | Phenotyping Reagent | Used to detect the presence of the Fyb antigen on human red cells. |
| Anti-k (Cellano) | Phenotyping Reagent | Used to detect the presence of the k (Cellano) antigen on human red cells. |
| Anti-Kpa | Phenotyping Reagent | Used to detect the presence of the Kpa antigen on human red cells. |
B |
| BenPen | Antibiotics | Used to treat infections caused by susceptible bacteria. |
| BERINERT® | Critical Care | Used for the treatment of acute attacks in patients with hereditary angioedema. |
| BIOSTATE® | Coagulation Disorders | Used for patients with haemophilia A, in which there are reduced levels of factor VIII. |
| BIOSTATE® | Coagulation Disorders | Used for patients with haemophilia A, in which there are reduced levels of factor VIII. |
| BIOSTATE® | Coagulation Disorders | Used for patients with haemophilia A, in which there are reduced levels of factor VIII. |
| BIOSTATE® | Coagulation Disorders | Used for patients with haemophilia A, in which there are reduced levels of factor VIII. |
| BIOSTATE™ | Coagulation Disorders | Used for patients with haemophilia A, in which there are reduced levels of factor VIII. |
| Black Snake Antivenom | | For the treatment of symptoms of a venomous bite. |
| Bovine Albumin 22% Solution | Supplementary Reagent | Used to enhance the agglutination of red cells in antibody detection tests. |
| Bovine Albumin 30% Solution | Supplementary Reagent | Used to enhance the agglutination of red cells in antibody detection tests. |
| Box Jellyfish Antivenom | | For the treatment of symptoms of a venomous sting. |
| Brown Snake Antivenom | | For the treatment of symptoms of a venomous bite. |
| Burinex | Urology | Indicated for the treatment of oedema, particularly when associated with congestive heart failure, hepatic and renal diseases. |
C |
| Celpresol™ | Supplementary Reagent | Designed for the preservation, suspension and resuscitation of human red blood cells. |
| Celpresol™ LISS | Supplementary Reagent | Designed for the preservation, suspension and resuscitation of human red blood cells. |
| Cervidil | Obstetrics and Gynecology | Used by women who have a normal pregnancy and are near their due date for delivery to prepare for induction. |
| CMV Immunoglobulin-VF | Immune Therapy | Used to help prevent cytomegalovirus infection in specific transplant patients. |
| COMVAX® | | For the prevention of Haemophilus influenza type b and hepatitis B infection. |
Controcell™ 2
(EU and US only) | Reagent Red Blood Cells | Designed to control, standardise and validate all routine immunohaematology tests. |
Controcell™ 4
(EU and US only) | Reagent Red Blood Cells | Designed to control, standardise and validate all routine immunohaematology tests. |
| Cord Cells 3% | Reagent Red Blood Cells | Used for confirming the presence of anti-I in an antibody identification procedure. |
D |
| Daivobet | Dermatology | Used in the type of psoriasis, where 'plaques' form in the skin. |
| Daivonex | Dermatology | Used in mild to moderate chronic plaque type psoriasis. |
| Death Adder Antivenom | | For the treatment of symptoms of a venomous bite. |
E |
| Epiclone™-2 Anti-D (IgM/IgG) | RhD Reagent | Designed for routine RhD typing of human red cells. |
| Epiclone™-2 Anti-D (IgM) | RhD Reagent | Used to detect the presence of RhD positive human red cells. |
| Epiclone™ AHG Poly | Anti-Human Globulin Reagent | Used for detection of clinically relevant IgG subtypes. |
| Epiclone™ Anti-A | ABO Reagent | Used to detect the presence of the A antigen on human red cells. |
| Epiclone™ Anti-A/B | ABO Reagent | Used to detect the presence of the A and B antigens on human red cells. |
| Epiclone™ Anti-B | ABO Reagent | Used to detect the presence of the B antigen on human red cells. |
| Epiclone™ Anti-c | Phenotyping Reagent | Used to detect the presence of the c antigen on human red cells. |
| Epiclone™ Anti-C | Phenotyping Reagent | Used to detect the presence of the C antigen on human red cells. |
| Epiclone™ Anti-Cw | Phenotyping Reagent | Used to detect the presence of the Cw antigen on human red cells. |
| Epiclone™ Anti-C3d | Anti-Human Globulin Reagent | Used to only detect the clinically relevant complement components in relation to Anti-C3d. |
| Epiclone™ Anti-DCE | Phenotyping Reagent | Used to detect the presence of the D, C and E antigens on human red cells. |
| Epiclone™ Anti-e | Phenotyping Reagent | Used to detect the presence of the e antigen on human red cells. |
| Epiclone™ Anti-E | Phenotyping Reagent | Used to detect the presence of the E antigen on human red cells. |
| Epiclone™ Anti-Jka | Phenotyping Reagent | Used to detect the presence of the Jka antigen on human red cells. |
| Epiclone™ Anti-Jkb | Phenotyping Reagent | Used to detect the presence of the Jkb antigen on human red cells. |
| Epiclone™ Anti-K (Kell) | Phenotyping Reagent | Used to detect the presence of the K antigen on human red cells. |
| Epiclone™ Anti-Lea | Phenotyping Reagent | Used to detect the presence of the Lea antigen on human red cells. |
| Epiclone™ Anti-Leb | Phenotyping Reagent | Used to detect the presence of the Leb antigen on human red cells. |
| Epiclone™ Anti-M | Phenotyping Reagent | Used to detect the presence of the M antigen on human red cells. |
| Epiclone™ Anti-N | Phenotyping Reagent | Used to detect the presence of the N antigen on human red cells. |
| Epiclone™ Anti-P1 | Phenotyping Reagent | Used to detect the presence of the P1 antigen on red blood cells. |
| Epiclone™ Anti-s | Phenotyping Reagent | Used to detect the presence of the s antigen on human red cells. |
| Epiclone™ Anti-S | Phenotyping Reagent | Used to detect the presence of the S antigen on human red cells. |
F |
| Finacea | Dermatology | Topical treatment for papulo-pustular rosacea and mild-to-moderate acne vulgaris. |
| Flomaxtra | Urology | Treatment for men which relieves the lower urinary tract symptoms (LUTS) associated with a condition called benign prostatic hyperplasia (BPH). |
| Fluvax® | | For the prevention of influenza. |
| Fucidin | Antibiotics | Used to treat serious infections caused by susceptible bacteria that have not responded to other antibiotics. |
| Funnel Web Spider Antivenom | | For the treatment of symptoms of a venomous bite. |
G |
| GARDASIL® | | For the prevention of cervical, vulvar, vaginal and anal cancer, and genital warts caused by Human Papillomavirus (HPV) Types 6,11,16 & 18. |
H |
| H-B-VAX II® | | For the prevention of hepatitis B infection. |
| Hepatitis B Immunoglobulin-VF | Immune Therapy | Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. |
| Hepatitis B Immunoglobulin-VF | Immune Therapy | Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. |
I |
| INTRAGAM® P | Immune Therapy | Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. |
| INTRAGAM® P | Immune Therapy | Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. |
| INTRAGAM® P | Immune Therapy | Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. |
| INTRAGAM® P | Immune Therapy | Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. |
| INTRAGAM® P | Immune Therapy | Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. |
L |
| LISS | Supplementary Reagent | Designed for use in tube technique antibody screening, identification and cross matching. |
M |
| Menjugate® | | For the prevention of meningococcal group C infection. |
| MERUVAX II® | | For the prevention of rubella. |
| Minijet Adrenaline | Emergency Care | Used in the management of Cardiac Arrest. |
| Minijet Atropine Sulfate | Emergency Care | Used in the management of heart rate abnormalities following Cardiac Arrest. |
| Minijet Calcium Chloride | Emergency Care | Used in the management of Cardiac Arrest and treating specific biochemical abnormalities in the blood. |
| Minijet Glucose | Emergency Care | Used in the management of low blood sugar level that has led to loss of consciousness. |
| Minijet Lignocaine Hydrochloride | Emergency Care | Used to correct severe abnormalities of cardiac rhythm. |
| Minijet Naloxone Hydrochloride | Emergency Care | Used in the management of overdose of any opioid medication. |
| Minijet Sodium Bicarbonate | Emergency Care | Used to help correct the biochemical abnormality of excess acid in the blood which results from Cardiac Arrest. |
| Modavigil | Central Nervous System | A wakefulness-promoting agent for oral administration. |
| MonoFIX®-VF | Coagulation Disorders | Used in patients with haemophilia B, in which there are reduced levels of Factor IX. |
| MonoFIX®-VF | Coagulation Disorders | Used in patients with haemophilia B, in which there are reduced levels of Factor IX. |
N |
| Albumex® 5 | Critical Care | Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. |
| 20% NSA | Critical Care | Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. |
| Albumex® 20 | Critical Care | Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. |
| ALBUMEX™ 20 | Critical Care | Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. |
| Normal Immunoglobulin-VF | Immune Therapy | Used for the replacement of antibodies to help prevent infections. |
| Normal Immunoglobulin-VF | Immune Therapy | Used for the replacement of antibodies to help prevent infections. |
P |
| Papain Solution | Supplementary Reagent | Used to treat human red cells in immunohaematological testing. |
| PedvaxHIB® | | For the prevention of Haemophilus influenza type b. |
| Phenocell 0.8% (C Panel) | Reagent Red Blood Cells | Used in identification of unexpected rare and unusual alloantibodies using Column Agglutination Technology (CAT) Systems. |
| Phenocell 3% (C Panel) | Reagent Red Blood Cells | Used in identification of unexpected rare and unusual alloantibodies using tube technique. |
| Phenocell™ 0.8% | Reagent Red Blood Cells | Used in identification of unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. |
| Phenocell™ 3% | Reagent Red Blood Cells | Used in identification of unexpected alloantibodies using tube technique. |
| PNEUMOVAX 23® | | For the prevention of pneumococcal infections. |
| Polyvalent Snake Antivenom | | For the treatment of symptoms of a venomous bite. |
| PROTHROMBINEX®-VF | Coagulation Disorders | Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. |
| PROTHROMBINEX™-HT | Coagulation Disorders | Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. |
| PROTHROMBINEX™-HT | Coagulation Disorders | Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. |
| PROTHROMBINEX™-VF | Coagulation Disorders | Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. |
Q |
| Q-VAX® | | For the prevention of Q fever. |
R |
| Rabipur® | | For the prevention of rabies. |
| RAM | Supplementary Reagent | Designed for use in tube technique antibody screening, identification and cross matching. |
| RAMPEG | Supplementary Reagent | Designed for use in tube technique antibody screening and identification. |
| Red Back Spider Antivenom | | For the treatment of symptoms of a venomous bite. |
| Revercell™ 0.8% | Reagent Red Blood Cells | Used to detect ABO blood group antibodies using Column Agglutination Technology (CAT) Systems. |
| Revercell™ 15% | Reagent Red Blood Cells | Used to detect ABO blood group antibodies using tile techniques. |
| Revercell™ 3% | Reagent Red Blood Cells | Used to detect ABO blood group antibodies using tube techniques. |
| Rh(D) Immunoglobulin-VF | Immune Therapy | Used to prevent Haemolytic Disease of the Newborn. |
| Rh(D) Immunoglobulin-VF | Immune Therapy | Used to prevent Haemolytic Disease of the Newborn. |
| RHOPHYLAC® | Immune Therapy | Used in large fetomaternal haemorrhage (FMH), or for inadvertent or emergency transfusion of Rh (D) positive blood to an Rh (D) negative female of childbearing potential. |
| RotaTeq® | | For the prevention of gastroenteritis. |
S |
| Scheriproct Ointment | Urology | Used in the treatment of haemorrhoids(piles), tears of the anal tissue, and similar conditions. |
| Sea Snake Antivenom | | For the treatment of symptoms of a venomous bite. |
| Securacell™ | Reagent Red Blood Cells | Designed to control, standardise and validate all routine immunohaematology tests. |
| Securacell™ Light | Reagent Red Blood Cells | Designed to control, standardise and validate all routine immunohaematology tests. |
| Snake Venom Detection Kit (SVDK) | Snake Venom Detection | Designed to assist in selection of most appropriate monovalent antivenom therapy. |
| Solaraze | Dermatology | Used to manage the skin condition known as actinic or solar keratosis. |
| Stonefish Antivenom | | For the treatment of symptoms of a venomous sting. |
T |
| Taipan Antivenom | | For the treatment of symptoms of a venomous bite. |
| Tetanus Immunoglobulin-VF IM | Immune Therapy | Used to help prevent tetanus in a person who has not recently been immunised against tetanus. |
| Tetanus Immunoglobulin-VF IM | Immune Therapy | Used to help prevent tetanus in a person who has not recently been immunised against tetanus. |
| Tetanus Immunoglobulin-VF IV | Immune Therapy | Used to treat tetanus infection. |
| THROMBOTROL®-VF | Critical Care | Used for the treatment patients with conditions relating to an inherited deficiency of antithrombin III. |
| THROMBOTROL®-VF | Critical Care | Used for the treatment of patients with conditions relating to an inherited deficiency of antithrombin III. |
| Tiger Snake Antivenom | | For the treatment of symptoms of a venomous bite. |
| Tramal | Analgesia | Used to treat moderate to severe pain. |
V |
| Vaniqa | Dermatology | Used to delay the regrowth of unwanted facial hair in women. |
| VAQTA® | | For the prevention of hepatitis A infection. |
| VARIVAX Refrigerated® | | For the prevention of chickenpox. |
| Venom Practice Kit (VPK) | Snake Venom Detection | Used in identifying snake immunotype for selecting appropriate antivenoms. |
| Vesicare | Urology | For the treatment of overactive bladder. |
| Vivotif Oral® | | For the prevention of typhoid. |
Z |
| ZOSTAVAX® | | For the prevention of shingles. |
| Zoster Immunoglobulin-VF | Immune Therapy | Used to help prevent chickenpox and shingles. |
| Zoster Immunoglobulin-VF | Immune Therapy | Used to help prevent chickenpox and shingles. |